Trials / Completed
CompletedNCT02798679
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether pre-existing cardiac fibrosis is a predictor of cancer treatment-related cardiotoxicity.
Conditions
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2016-06-14
- Last updated
- 2022-10-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02798679. Inclusion in this directory is not an endorsement.